BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22130965)

  • 1. Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death.
    Kelesidis I; Travin MI
    J Nucl Cardiol; 2012 Feb; 19(1):142-52; quiz 153-7. PubMed ID: 22130965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
    Kawai T; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Takahashi S; Ishimi M; Hakui H; Ozaki T; Sato Y; Seo M; Sakata Y; Fukunami M
    Am J Cardiol; 2015 Jun; 115(11):1549-54. PubMed ID: 25851796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
    Tamaki S; Yamada T; Okuyama Y; Morita T; Sanada S; Tsukamoto Y; Masuda M; Okuda K; Iwasaki Y; Yasui T; Hori M; Fukunami M
    J Am Coll Cardiol; 2009 Feb; 53(5):426-35. PubMed ID: 19179201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
    Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal left ventricular ejection fraction cut-off for risk stratification for primary prevention of sudden cardiac death early after myocardial infarction?
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Europace; 2014 Sep; 16(9):1315-21. PubMed ID: 24599939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy.
    Fallavollita JA; Heavey BM; Luisi AJ; Michalek SM; Baldwa S; Mashtare TL; Hutson AD; Dekemp RA; Haka MS; Sajjad M; Cimato TR; Curtis AB; Cain ME; Canty JM
    J Am Coll Cardiol; 2014 Jan; 63(2):141-9. PubMed ID: 24076296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nuclear cardiac imaging in risk stratification of sudden cardiac death.
    Juneau D; Erthal F; Chow BJ; Redpath C; Ruddy TD; Knuuti J; Beanlands RS
    J Nucl Cardiol; 2016 Dec; 23(6):1380-1398. PubMed ID: 27469611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification for sudden cardiac death in North America - current perspectives.
    Buxton AE; Waks JW; Shen C; Chen PS
    J Electrocardiol; 2016; 49(6):817-823. PubMed ID: 27524476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.
    Wakabayashi T; Nakata T; Hashimoto A; Yuda S; Tsuchihashi K; Travin MI; Shimamoto K
    J Nucl Med; 2001 Dec; 42(12):1757-67. PubMed ID: 11752070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
    Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
    Dagres N; Hindricks G
    Eur Heart J; 2013 Jul; 34(26):1964-71. PubMed ID: 23644180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.
    Wu KC
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28637807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
    Kiuchi MG; Nolde JM; Villacorta H; Carnagarin R; Chan JJS; Lugo-Gavidia LM; Ho JK; Matthews VB; Dwivedi G; Schlaich MP
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden death in ischemic heart disease - 2017.
    Buxton AE
    Int J Cardiol; 2017 Jun; 237():64-66. PubMed ID: 28365181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of I-123 Metaiodobenzylguanidine Imaging in Management of Patients With Heart Failure.
    Wolinsky D; Hendel R; Cerqueira M; Gold M; Narula J; Singh J; Shaw L; Thomas G; Wazni O; Farnum C
    Am J Cardiol; 2015 Oct; 116 Suppl 1():S1-9. PubMed ID: 26454812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction.
    Waks JW; Buxton AE
    Annu Rev Med; 2018 Jan; 69():147-164. PubMed ID: 29414264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.